Periurethral fibrosis secondary to prostatic inflammation causing lower urinary tract symptoms: A prospective cohort study

Urology

Volumn 81, Issue 5, 2013, Pages 1018-1024

  Cantiello, Francesco ^a   Cicione, Antonio ^a   Salonia, Andrea ^b   Autorino, Riccardo ^c,e   Tucci, Luigi ^d   Madeo, Immacolata ^a   Damiano, Rocco ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c LERNER RESEARCH INSTITUTE   (United States)

^d PUGLIESE CIACCIO HOSPITAL   (Italy)

^e SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; ELASTIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; FIBROSIS; GLEASON SCORE; HUMAN; HUMAN TISSUE; INFLAMMATORY INFILTRATE; INTERNATIONAL PROSTATE SYMPTOM SCORE; LOWER URINARY TRACT SYMPTOM; LYMPH NODE; MALE; PERIURETHRAL FIBROSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE SIZE; PROSTATE VOLUME; PROSTATECTOMY; PROSTATITIS; URETHRA DISEASE; URODYNAMICS;

EID: 84876562558     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2013.01.053     Document Type: Article

References (30)

1. A. Briganti, U. Capitanio, and N. Suardi Benign prostatic hyperplasia and its aetiologies Eur Urol Suppl 8 2009 865 871
2. K.L. Lee, and D.M. Peehl Molecular and cellular pathogenesis of benign prostatic hyperplasia J Urol 172 2004 1784 1791
3. A. Sciarra, F. Di Silverio, and S. Salciccia Inflammation and chronic prostatic diseases: evidence for a link? Eur Urol 52 2007 964 972
4. B. Fibbi, G. Penna, and G. Morelli Chronic inflammation in the pathogenesis of benign prostatic hyperplasia Int J Androl 33 2010 475 488
5. G. Robert, A. Descazeaud, and Y. Allory Should we investigate prostatic inflammation for the management of benign prostatic hyperplasia? Eur Urol Suppl 8 2009 879 886
6. C. De Nunzio, G. Kramer, and M. Marberger The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation Eur Urol 60 2011 106 117
7. B. Chughtai, R. Lee, A. Te, and S. Kaplan Role of inflammation in benign prostatic hyperplasia Rev Urol 13 2011 147 150
8. J.C. Nickel, J. Downey, and I. Young Asymptomatic inflammation and/or infection in benign prostatic hyperplasia BJU Int 84 1999 976 981
9. G. Kramer, D. Mitteregger, and M. Marberger Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? Eur Urol 51 2007 1202 1216
10. C.G. Roehrborn, S.A. Kaplan, and W.D. Noble The impact of acute or chronic inflammation in baseline biopsy on the risk of clinical progression of BPH: results from the MTOPS study J Urol 173 2005 346 351
11. J. Ma, M. Gharaee-Kermani, and L. Kunju Prostatic fibrosis is associated with lower urinary tract symptoms J Urol 188 2012 1375 1381
12. S. Detlefsen, B. Sipos, and B. Feyerabend Pancreatic fibrosis associated with age and ductal papillary hyperplasia Virchows Arch 447 2005 800 805
13. M.Y. Donath, D.M. Schumann, and M. Faulenbach Islet inflammation in type 2 diabetes: from metabolic stress to therapy Diabetes Care 31 suppl 2 2008 161 164
14. M. Gharaee-Kermani, B. Hu, and S.H. Phan Recent advances in molecular targets and treatment of idiopathic pulmonary fibrosis: focus on TGFbeta signaling and the myofibroblast Curr Med Chem 16 2009 1400 1417
15. W. Schafer, P. Abrams, and L. Liao Good urodynamic practices: uroflowmetry, filling cystometry and pressure-flow studies Neurourol Urodyn 21 2002 261 274
16. W. Schafer Principles and clinical application of advanced urodynamic analysis of voiding function Urol Clin North Am 17 1990 553 566
17. C.S. Lim, and P. Abrams The Abrams-Griffiths nomogram World J Urol 13 1995 34 39
18. O. Tanaka, S. Hayashi, and M. Matsuo Comparison of urethral diameters for calculating the urethral dose after permanent prostate brachytherapy Radiat Med 25 2007 329 334
19. J. Irani, P. Levillain, and J.M. Goujon Inflammation in benign prostatic hyperplasia: correlation with prostate specific antigen value J Urol 157 1997 1301 1303
20. J.C. Nickel, C.G. Roehrborn, and M.P. O'Leary The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial Eur Urol 54 2008 1379 1384
21. G. Robert, A. Descazeaud, and N. Nicolaiew Inflammation in benign prostatic hyperplasia: a 282 patients' immunohistochemical analysis Prostate 69 2009 1774 1780
22. F. Di Silverio, V. Gentile, and A. De Matteis Distribution of inflammation, pre-malignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: a retrospective analysis Eur Urol 43 2003 164 175
23. J. St Sauver, D. Jacobson, and M. McGree Protective association between nonsteroidal antiinflammatory drug use and measures of benign prostatic hyperplasia Am J Epidemiol 164 2006 760 768
24. S. Sutcliffe, R. Grubb 3rd., and E. Platz Non-steroidal anti-inflammatory drug use and the risk of benign prostatic hyperplasia-related outcomes and nocturia in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial BJU Int 110 2012 1050 1059
25. A. Bardia, E.A. Platz, and S. Yegnasubramanian Anti-inflammatory drugs, antioxidants, and prostate cancer prevention Curr Opin Pharmacol 9 2009 419 426
26. F. Di Silverio, C. Bosman, and M. Salvatori Combination therapy with rofecoxib and finasteride in the treatment of men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH) Eur Urol 47 2005 72 79
27. R. Vela Navarrete, J.V. Garcia Cardoso, and A. Barat BPH and inflammation: pharmacological effects of Permixon on histological and molecular inflammatory markers. Results of a double blind pilot clinical assay Eur Urol 44 2003 549 555
28. D. Iglesias-Gato, T. Carsten, and M. Vesterlund Androgen-independent effects of Serenoa repens extract (Prostasan®) on prostatic epithelial cell proliferation and inflammation Phytother Res 26 2012 259 264
29. A. Latil, C. Libon, and M. Templier Hexanic lipidosterolic extract of Serenoa repens inhibits the expression of two key inflammatory mediators, MCP-1/CCL2 and VCAM-1, in vitro BJU Int 110 2012 E301 307
30. T. Feruno, T. Demura, and T. Kaneta Difference of cancer core distribution between first and repeat biopsy in patients diagnosed by extensive transperineal ultrasound guided template prostate biopsy Prostate 58 2004 76 81